ECOLOGY AND GENETICS OF VENEZUELAN EQUINE ENCEPHALITIS
ECOLOGY AND GENETICS OF VENEZUELAN EQUINE ENCEPHALITIS
批准号:
6748562
负责人:
Scott C Weaver
金额:
$41.56万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2006-05-31
关键词:
AvesChiropteraVenezuelan equine encephalitis viruscommunicable disease controlcommunicable disease transmissiondisease outbreaksecologyemerging infectious diseaseepizootiologyfield studygene mutationgeographic siteglycoproteinsinfectious encephalitisinformation systemsmolecular cloningprotein structure functionsite directed mutagenesistelemetryvirulencevirus envelopevirus load
中文摘要
描述:委内瑞拉马脑炎(VEE)是一种新兴的虫媒病毒
疾病以及整个美洲的公共和兽医健康威胁,
包括美国在内最近在南美洲和墨西哥爆发的疫情
强调了VEE出现的持续威胁。VEE病毒集中体现了
RNA病毒突变和改变其宿主范围和疾病的能力
模式,并代表理想的模型系统的研究RNA-和
虫媒病毒病的出现。VEE研究60年的开创性问题
一直是导致人类和马的主要疾病的菌株的来源
爆发我们的流行病学和遗传学研究表明,
LkB和IC亚型动物流行病毒是从地方流行的ID亚型病毒进化而来的
在委内瑞拉和哥伦比亚持续流通。反向遗传学研究
表明少量的突变可以产生亚型IC菌株,
ID祖细胞,并暗示带正电荷的E2包膜糖蛋白氨基
1992-93年爆发的酸变化。实地研究发现,
祖先地方病传播周期的关键宿主,以及
卫星图像已经被开发用于预测广泛的地理范围
地方性病毒传播的地点流行病学和遗传学
数据还表明,动物流行病病毒在停止
爆发,提高了VEE出现的可能性,而不需要
突变所有这些突发事件都对公共卫生
影响
使用感染性cDNA克隆技术的独特组合,
感染,和实地研究,拟议的研究将回答关键,
关于VEE出现的剩余问题:1)在E2中进行类似的更改
糖蛋白解释了先前LkB和IC动物流行病毒的出现; 2)
地方流行的VEE病毒的其他基因型是否能够突变成为
动物流行病,还是地方流行病祖先的遗传骨干限制了它的
能变成马的毒力吗3)动物流行病病毒是如何通过
在森林生境中的地方病菌株突变,转移到
在生态条件允许爆发的地方?还有,4)
动物流行性菌株在停止感染后持续存在,
爆发?
我们的研究结果将促进对VEE出现机制的理解,
预测拉丁美洲和佛罗里达可能出现的地点。这
信息对于确定预防和控制资源的目标是非常宝贵的,
特别是为了在发展中国家获得最大利益,
资源
英文摘要
DESCRIPTION: Venezuelan equine encephalitis (VEE) is an emerging arboviral
disease and a public and veterinary health threat throughout the Americas,
including the United States. Recent outbreaks in South America and Mexico
underscore the continued threat of VEE emergence. VEE virus epitomizes the
ability of RNA viruses to mutate and alter their host range and disease
patterns, and represents ideal model systems for the study of RNA- and
arboviral disease emergence. The seminal question in 60 years of VEE research
has been the source of the strains responsible for major human and equine
outbreaks. Our epidemiological and genetic studies indicate that epizootic,
subtype LkB and IC epizootic viruses evolve from enzootic, subtype ID viruses
that circulate continuously in Venezuela and Colombia. Reverse genetic studies
indicate that small numbers of mutations can generate subtype IC strains from
ID progenitors, and implicate positively charged E2 envelope glycoprotein amino
acid changes in emergence of a 1992-93 outbreak. Field studies have identified
the critical hosts of the progenitor enzootic transmission cycles, and
satellite imagery has been developed to predict over a broad geographical range
the locations where enzootic viruses circulate. Epidemiological and genetic
data also suggest that epizootic viruses persist following the cessation of
outbreaks, raising the possibility of VEE emergence without the need for
mutation. All of these emergence scenarios have profound public health
implications.
Using a unique combination of infectious cDNA clone technology, experimental
infections, and field studies, the proposed research will answer critical,
remaining questions regarding VEE emergence: 1) do similar changes in the E2
glycoprotein explain the emergence of previous LkB and IC epizootic viruses; 2)
are other genotypes of enzootic VEE viruses capable of mutating to become
epizootic, or does the genetic backbone of the enzootic progenitor limit its
ability to become equine virulent? 3) How are epizootic viruses, generated via
mutation of enzootic strains in sylvatic habitats, transported to locations
where ecological conditions permit the initiation of outbreaks? And, 4) do
epizootic strains persist in continuous cycles following the cessation of
outbreaks?
Our results will advance understanding of VEE emergence mechanisms, and will
predict locations of potential emergence in Latin America and Florida. This
information will be invaluable in targeting prevention and control resources,
especially for obtaining maximum benefit in developing countries with limited
resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
West African Center for Emerging Infectious Diseases
-
批准号:10427336
-
项目类别:
-
资助金额:$154.36万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
West African Center for Emerging Infectious Diseases
-
批准号:10187519
-
项目类别:
-
资助金额:$154.53万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
West African Center for Emerging Infectious Diseases
-
批准号:10626824
-
项目类别:
-
资助金额:$154.22万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
West African Center for Emerging Infectious Diseases
-
批准号:10468361
-
项目类别:
-
资助金额:$52.1万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:10598513
-
项目类别:
-
资助金额:$98.75万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:9210602
-
项目类别:
-
资助金额:$92.49万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:8999458
-
项目类别:
-
资助金额:$76.95万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:10170884
-
项目类别:
-
资助金额:$98.75万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:10391524
-
项目类别:
-
资助金额:$98.75万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
Eastern Equine Encephalitis Emergence in Panama
-
批准号:8927903
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2015
-
负责人:Scott C Weaver
-
依托单位:
Trajectory of Vector-adaptive Chikungunya Virus Evolution
-
批准号:9009006
-
项目类别:
-
资助金额:$46.92万
-
财政年份:2015
-
负责人:Scott C Weaver
-
依托单位:
Trajectory of Vector-adaptive Chikungunya Virus Evolution
-
批准号:9185262
-
项目类别:
-
资助金额:$45.41万
-
财政年份:2015
-
负责人:Scott C Weaver
-
依托单位:
Eastern Equine Encephalitis Emergence in Panama
-
批准号:9091415
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2015
-
负责人:Scott C Weaver
-
依托单位:
Alphavirus Vaccines for Biodefense
-
批准号:8377052
-
项目类别:
-
资助金额:$90.69万
-
财政年份:2012
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8520171
-
项目类别:
-
资助金额:$95.44万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8308393
-
项目类别:
-
资助金额:$56.35万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8704359
-
项目类别:
-
资助金额:$64.2万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8077195
-
项目类别:
-
资助金额:$100.72万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS
-
批准号:8361058
-
项目类别:
-
资助金额:$2.45万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Alphavirus Vaccines for Biodefense
-
批准号:8233016
-
项目类别:
-
资助金额:$98.79万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
海外基金